search 


  home about us creating value our technologies pipeline news & events

studies

  site map
  Partners

"Our partnership with PARI has given us access to
their eFlow® Technology, their expertise in drug formulations and the complex interaction between the two. The eFlow Technology devices performed well in the Corus Phase 2 clinical trials and is being utilized in our Phase 3 program. We are excited about the potential of bringing our product to market which will be the first commercially available product for use
specifically with eFlow Technology devices."

                                         Bruce Montgomery, MD
                                         Gilead Sciences

We can take on various roles in our pharmaceutical partner relationships  Often we develop a comprehensive aerosol therapy development program that includes all formulation development, formulation and device optimization, development of analytical methods and aerosol testing, and regulatory support. However, if our pharma partner is in advanced development with a given formulation, we can focus our efforts on optimization of the Advanced Aerosol Delivery platform (e.g. eFlow Technology) and optimize the formulation to the device.  Mutual Business Development conditions are dictated by each partner’s contributions to the project.

[enlarge view]

 
 
 
 
 
 
 

 


     home  |  about us  |  creating value  |  our technologies  |  pipeline  |  news & events  |  studies

     © 2006-2008 PARI GmbH. All Rights Reserved.


PARI - 100 Years - Specialists in effective inhalation